A Novel Treg Augmenting Therapy for Patients with Alopecia Areata

Principal Investigator:
Michael D. Rosenblum, MD
Sponsoring Institution:
University of California San Francisco


If successful, this study may help pave the way for future clinical trials testing the safety and efficacy of regulatory T cell (Treg) augmenting therapies in patients with alopecia areata.


This project will examine the function of regulatory T cells (Tregs) in the activation and differentiation of hair follicle stem cells in alopecia areata and determine whether the activity of Tregs can be modulated in alopecia areata using a novel IL-2 molecule.